EFTA00036889.pdf

Type: pdf
Source set: data-set-8
Extracted text

Let's shoot for Thursday or Friday. 
Sent from my Verizon, Samsung Galaxy smartphone 
 
 Ori inal messa e 
From: 
< 
Date: 8/13/19 2:13 PM (GMT-05:00) 
To: '  
Subject: Re: Fwd: 6031_03C.PATIENT CARE 
> » " 
08/13/2019 14:14 > » 
I know you have lot to do. Do you want to perform the Mortality Review for inmate Epstien this week? We have 30 days to 
complete the review. The people that need to be present 
are the CD, HSA, 1-MLP and AW over Health Services. I'm on leave next week. 
Very Res ectfull 
CDR 
EXT: 6315 Human Resources Training Room 
>>>I
 
Right. 
Associate Warden 
MCC New York 
150 Park Row 
New York New York 10007 
Office: 
Black Be 
>>  >
No problem, but will need time to look up policies and procedures for each specific thing. 
8/13/2019 1:27 PM >> > 
8/13/2019 12:31 PM >>> 
Thank ou 
CDR 
>> > 
8/13/2019 11:57 AM >>> 
The Supplement is outdated and needs to be updated. Not only with the Naloxone but with other information. You will 
need to review the entire supplement for updates. Thanks. 
Associate Warden 
MCC New York 
150 Park Row 
New York New York 10007 
Office: 
Black Berr 
EFTA00036889


» 
8/13/2019 10:26 AM > » 
Hi AW 
we can add the Naloxone information in this supplement. I will place Naloxone information in this 
Supplement and send it to you for your review and if you are OK with it and the Warden is OK with it, we have him sign. 
Very respectfully, 
CDR S 
MSA, CCN, USPHS 
Health Services Administrator 
Metropolitan Correctional Center 
150 Park Row, New York, New York 10007 
Office 
>>> 
Good Morning, 
8/13/2019 10:03 AM >> > 
We need to find time to review the attached Supplement to ensure it is up to date. I would like to add the Naloxone in it 
instead of creating a new Supplement just for Naloxone. This is what the other institutions have done. Your thoughts? 
Thanks. 
Associate Warden 
MCC New York 
150 Park Row 
New York, New York 10007 
Office: 
Black Ber 
> » 
8/12/2019 10:54 AM > » 
Please see the attached. 
EFTA00036890
Open in the interactive archive →